The global pet diabetes care devices market is experiencing significant growth, with a current valuation of USD 2.3 billion in 2023 and an anticipated increase to USD 4.3 billion by 2033. This growth, fueled by a robust Compound Annual Growth Rate (CAGR) of 6.2% over the forecast period, underscores the expanding demand for advanced pet healthcare solutions.
Veterinary clinics are at the forefront of this market expansion, playing a pivotal role in driving the adoption of pet diabetes care devices. Healthcare professionals and animal caretakers within these clinics are increasingly recommending and utilizing these devices to enhance the management of pet health. These advanced devices are critical for detecting, monitoring, and managing common health issues in pets, thereby preventing complications and ensuring better overall care.
The rising awareness among pet owners, coupled with the proactive approach of veterinary clinics, is significantly boosting the adoption of diabetes care devices. By integrating these devices into routine care, pet owners can effectively manage their pets’ health, leading to an improved quality of life for their beloved companions.
Pet diabetes care devices, including insulin pens, glucose monitoring systems, and glucose meters, are designed in various sizes and shapes, featuring advanced functionalities for ease of use. Veterinary clinics not only inform pet owners about their pets’ conditions but also guide them on the benefits and usage of these devices. Additionally, they educate pet owners on the importance of providing nutritious food and regularly monitoring blood glucose levels.
With the number of pets diagnosed with diabetes on the rise, the demand for pet diabetes care devices is surging. Veterinary clinics are instrumental in expanding the market by offering pet owners effective tools to support their pets’ health conditions, providing comprehensive training on the use of these devices, and ensuring regular monitoring at home.
The global pet diabetes care devices market is poised for continued growth as veterinary clinics continue to champion advanced pet health management solutions, empowering pet owners to take charge of their pets’ well-being.
Key Takeaways:
- The pet diabetes care devices market is registering a CAGR of 6.2% with a valuation of USD 4.3 billion by 2033.
- In the historical period, the market captured a CAGR of 5.7%, with a valuation of USD 1.7 billion in 2018.
- The United States is a prominent leader in the global market, registering a share of 27% during the forecast period.
- China is one of the significant countries in the Asia Pacific that securing a CAGR of 8.20% by 2033.
- During the forecast period, India is registering a CAGR of 7.50% in the global market.
Find the Freshest Reports from Get Old Source
How Key Players are Focus on Adding Values in the Global Market?
Key players are focusing on innovating pet diabetes care devices by adding advanced features resulting in accuracy, convenience, and ease to use. The key players are deploying small sensors in these devices to monitor pets’ health conditions, such as blood glucose levels. These devices work on a real-time basis as pet owners track the condition of their pets and provide them with healthy nutrition with a proper dietary plan.
The key players developing specially design insulin syringes to provide more accurate information than other devices. These devices provide quick results, increasing the adoption of pet healthcare to treat pets’ poor health conditions. Conversely, guiding pet owners, growing awareness, and innovating easy-to-access pet care devices improve pet health.
Recent Developments in the Global Pet Diabetes Care Devices Market are:
- In September 2021, Zoetis Inc launched its new product VETSCAN IMAGYST. This device offers to monitor pets’ diabetes and health conditions.
- In July 2021, Merck Animal Health launched Vetsulin to manage pets’ diabetes.
- In 2020, IDEXX Laboratories announced its new product device IDEXX SDMA Test to identify kidney disease in cats and dogs and also the complication of diabetes.
- In 2019, Vetoquinol announced its acquisition with Epitopix to provide vaccination for diabetes-diagnosed pets.
Other Essential Players in the Global Market are:
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol S.A.
Pet Diabetes Care Devices Market by Category:
By Animal Type:
- Cats
- Dogs
- Horses
By Device:
- Insulin Delivery Devices
- Insulin Delivery Pen
- Insulin Syringes
- Glucose Monitoring Devices
By End User:
- Veterinary Clinics
- Home Care Settings
- Veterinary Hospitals
Region:
- North America
- Europe
- Latin America
- Asia Pacific
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube